Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 12Gliosarcoma 11Glioblastoma 11Prostatic Neoplasms 7Lung Neoplasms 6Head and Neck Neoplasms 6Breast Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Pancreatic Neoplasms 5Brain Neoplasms 4Astrocytoma 4Adenocarcinoma of Lung 3Wilms Tumor 2Uterine Cervical Neoplasms 2Sarcoma 2Salivary Gland Neoplasms 2Rectal Neoplasms 2Pinealoma 2Oligodendroglioma 2Meningioma 2Medulloblastoma 2Malignant mesenchymal tumor 2Liver Neoplasms 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Hemangiosarcoma 2Glioma 2Fibrosarcoma 2Ependymoma 2

Interventions

Gemcitabine 23Capecitabine 17Cisplatin 11Oxaliplatin 10Fluorouracil 9Leucovorin 8Irinotecan 7Erlotinib Hydrochloride 6pembrolizumab 5Radiotherapy 5Sorafenib 4Interleukin-12 Subunit p35 3Cholangiopancreatography, Endoscopic Retrograde 3Carboplatin 3regorafenib 2dehydroftorafur 2Watchful Waiting 2Trastuzumab 2Pancreaticoduodenectomy 2N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl-6-(5-((methylsulfonyl)ethyl)aminomethyl)-2-furyl)-4-quinazolinamine 2Long-Term Synaptic Depression 2Lapatinib 2Filgrastim 2Epirubicin 2Drug Therapy 2Dihematoporphyrin Ether 2Chemotherapy, Adjuvant 2Bevacizumab 2trifluridine tipiracil drug combination 1tremelimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Bile Duct Neoplasms × Radiotherapy, Conformal × Clear all
NCT00789958 2018-04-09

S0809: Capecitabine, Gemcitabine, and RT in Patients w/Cholangiocarcinoma of the Gallbladder or Bile Duct

SWOG Cancer Research Network

Phase 2 Completed
105 enrolled 13 charts
Gastrointestinal

Bile Duct Neoplasms, Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡